Second-line chemotherapy with weekly paclitaxel and gemcitabine in platinum-etoposide pretreated patients with small cell lung cancer (SCLC): A single institution phase II trial

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 7209-7209 ◽  
Author(s):  
V. Dongiovanni ◽  
L. Buffoni ◽  
D. Dongiovanni ◽  
A. Addeo ◽  
C. Barone ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Single Institution ◽  
Pretreated Patients ◽  
Line Chemotherapy

scholarly journals Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: A phase II trial

2001 ◽  
Vol 12 (1) ◽  
pp. 89-94 ◽  
Author(s):  
C.H. Spiridonidis ◽  
L.R. Laufman ◽  
L. Carman ◽  
T. Moore ◽  
S. Blair ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy

A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer

Lung Cancer ◽  
2000 ◽  
Vol 29 (1) ◽  
pp. 67-73 ◽  
Author(s):  
J.P Sculier ◽  
J.J Lafitte ◽  
T Berghmans ◽  
J Thiriaux ◽  
J Lecomte ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Trial Testing ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document